By Gerteis Maschinen…
To get in touch with Gerteis Maschinen + Processengineering AG, simply fill out the form below.
Subscribe to Supplier
Gerteis brings upgraded roller compactor to P-MEC India
Jona, Switzerland: – Dry granulation expert Gerteis is returning to the P-MEC expo in Mumbai to show new solutions, including new technology for its renowned Mini-Pactor®, Macro-Pactor® and Minipolygran® roller compactors.
P-MEC is part of the huge CPhI India event, split over two Mumbai venues. The Gerteis stand is once again at Booth N2 in Hall 5 of the Bombay Exhibition Centre (BEC).
Gerteis will display the latest generation Mini-Pactor featuring various technology upgrades, including new HMI package and PLC-based redesign.
Designed primarily for R&D use, these machines feature sophisticated capabilities for small-scale continuous production under high containment, using constant ribbon measurement with minimal uncompacted fines.
The Gerteis P-MEC team will also be able to provide customers visiting its stand with face-to-face scientific and technical process advice from senior company experts.
“We are delighted to be returning to P-MEC India in this our 30th Anniversary year,” said Hartmut vom Bey, Gerteis VP for Sales &Technology.
“This event is a great opportunity to extend relationships and deepen partnerships with our growing customer base across South and East Asia looking for the most efficient and reliable dry granulation and compaction technology,” said Mr. vom Bey.
“The increasing sophistication of regional manufacturing operations is placing greater emphasis on safe handling of high potency active pharmaceutical ingredients, HPAPIs, where high containment and sophisticated granulation methods that protect operators and reduce exposure levels are key factors,” noted Mr. vom Bey.
“At P-MEC we will be able to show how our high containment roller compaction technologies form key parts of the solution, especially when teamed with our Ultra High Containment Options that can eliminate risk of contamination of manufacturing areas and exposure of personnel to toxic substances,” he added.
Gerteis Maschinen + Processengineering AG is a Swiss-based company that has rapidly established itself as a world leader in the field of premium roller compactors. The company’s products and services cover all aspects of dry granulation processes, with unparalleled experience in this field built up since the company was founded in 1986.
Gerteis manufactures a wide range of high quality containment roller compactors that are versatile enough to process a vast range of powders, even notoriously problematic ones at both laboratory and production scales. The company’s patented technologies are widely used by the pharmaceutical, chemical and food industries.
Rapidly increasing demand recently forced the company to move from its original site in Jona on the shores of Lake Zurich to larger and purpose designed premises nearby, in a move completed at the end of 2013.
As well as manufacturing machinery, Gerteis offers complete solution packages that help customers increase productivity including support on identifying ideal formulations and in-house training courses on dry granulation processing. Gerteis constantly seeks to expand its knowledge on dry granulation, participating in numerous research collaborations with German universities.
About P-MEC India 2017
The huge P-MEC India machinery and equipment show is an integral part of the landmark CPhI India pharmaceutical industry expo, now in its 12th year.
The two shows bring the highly successful worldwide UBM-organized franchise to one of the world’s biggest single pharma markets, combining two events in one.
CPhI/P-MEC India 2017 will be a six-day event shared between two venues, opening November 27 at the landmark Bombay Exhibition Centre (BEC) in Mumbai, followed by an opening the next day at the BKC center.
The combined shows are expected to attract more than 28,000 visitors and some 1,000 exhibitors from almost 100 countries worldwide.
CPhI India bills itself as serving the knowledge sharing and networking needs of the Indian pharma market, currently growing at 13 per cent annually, twice as fast as world average. India is adding new drugs research to its established strengths in generics and APIs.
The event is organized by UBM Live, with more information at: www.cphi.com/india/